INFO60
SpotlightTopics60sNEWQuizLogin
IndiaAI & TechBusinessTechnologySportsEntertainmentHealthScienceWorld
INFO60

Know more. Read less. What matters, fast.

Company

  • About
  • Contact
  • Editorial Policy
  • Corrections
  • Our desks
  • Publishers

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Account

  • Delete Account
  • Spotlight
  • Quick Cards
  • Topics
  • Web Stories
  • Hindi News

Free. One email a day. Unsubscribe anytime.

Editions

  • India
  • United States
  • United Kingdom
  • Canada
  • Australia
  • UAE & Gulf
  • Singapore
  • Hindi
  • All countries
© 2026 Info60. All rights reserved.
Home›health›Novo says its next-gen obesity drug tops Lilly rival in late-stage study
health

Novo says its next-gen obesity drug tops Lilly rival in late-stage study

By Info60 UK Desk•Summary of reporting by Reuters•Sep 21, 2026•0 views•
Novo says its next-gen obesity drug tops Lilly rival in late-stage study
Novo says its next-gen obesity drug tops Lilly rival in late-stage study
ONLY AVAILABLE IN PAID PLANS
Read Full Article

Share this story

Report an error

Up next

Related Stories

New test in Nottingham diagnoses MS without needle procedure

New test in Nottingham diagnoses MS without needle procedure

BBC

Devon and Cornwall families plea for more help in dementia battle

Devon and Cornwall families plea for more help in dementia battle

BBC

Middlesbrough FC Foundation cancer fitness group 'saved me'

Middlesbrough FC Foundation cancer fitness group 'saved me'

BBC

Girl,12, campaigns for healthier hospital food

Girl,12, campaigns for healthier hospital food

BBC

'A bleak picture': The Plymouth wards where men are facing premature death

'A bleak picture': The Plymouth wards where men are facing premature death

Plymouth Live

Comments (0)

Please login to comment

Login
💬

No comments yet. Be the first to comment!